Skip to main content
Clinical Trials/IRCT2014020216453N1
IRCT2014020216453N1
Completed
Phase 2

Evaluation of the effect of progesterone on latency period of preterm premature rupture of membrane in 24-34 weeks of gestation

Research chancelor of kerman University of Medical Sciences0 sites171 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Research chancelor of kerman University of Medical Sciences
Enrollment
171
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Research chancelor of kerman University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • obvious fluid passage or direct observation with speculum or by positive nitrazine test in gestational age of 24 to 34 week \- according to first trimester sonography or last menstrual period.
  • Exclusion criteria: anomalous fetus? multiple gestation? chorioamnionitis signs at the time of admission? fetal distress? abruptio placenta? placenta previa? IUGR? medical diseases of mother (DM, severe preeclampsia).

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials